These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17186240)

  • 81. In vitro screening for synergism of high-linear energy transfer 213Bi-radiotherapy with other therapeutic agents for the treatment of B-cell chronic lymphocytic leukemia.
    Vandenbulcke K; Thierens H; De Vos F; Philippé J; Offner F; Janssens A; Apostolidis C; Morgenstern A; Bacher K; de Gelder V; Dierckx RA; Slegers G
    Cancer Biother Radiopharm; 2006 Aug; 21(4):364-72. PubMed ID: 16999602
    [TBL] [Abstract][Full Text] [Related]  

  • 82. In vitro improvement of chlorambucil-induced cytotoxicity by deflazacort and 6-methylprednisolone in B-cell chronic lymphocytic leukaemia.
    Morabito F; Callea I; Irrera G; Cartisano G; Dattola A; Rodinò A; Brugiatelli M
    Eur J Haematol; 1997 May; 58(5):301-6. PubMed ID: 9222284
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Potentiation of chlorambucil toxicity in B-CLL lymphocytes using the DNA synthesis inhibitors aphidicolin and 1-beta-D-arabinofuranosylcytosine.
    Bramson J; Panasci L
    Biochem Pharmacol; 1995 Jun; 50(1):131-5. PubMed ID: 7605339
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Extensive exfoliative dermatitis induced by chlorambucil.
    Kilickap S; Kurt M; Aksoy S; Erman M; Turker A
    Am J Hematol; 2006 Nov; 81(11):891-2. PubMed ID: 16804936
    [No Abstract]   [Full Text] [Related]  

  • 85. Retinal detachments due to chronic lymphocytic leukaemia.
    Murphy JA; Pitts JF; Dudgeon J; Hogg RB; Harnett AN
    Clin Lab Haematol; 1991; 13(2):217-20. PubMed ID: 1934932
    [No Abstract]   [Full Text] [Related]  

  • 86. Inter- and intraindividual differences in oral chlorambucil pharmacokinetics.
    Hartvig P; Simonsson B; Oberg G; Wallin I; Ehrsson H
    Eur J Clin Pharmacol; 1988; 35(5):551-4. PubMed ID: 3069479
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Palladium and Platinum Complexes of the Antimetabolite Fludarabine with Vastly Enhanced Selectivity for Tumour over Non-Malignant Cells.
    Schleser SW; Krytovych O; Ziegelmeier T; Groß E; Kasparkova J; Brabec V; Weber T; Schobert R; Mueller T
    Molecules; 2023 Jul; 28(13):. PubMed ID: 37446835
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Enhanced clearance of leukemic lymphocytes in B-cell chronic lymphocytic leukemia with etodolac.
    Nardella FA; LeFevre JA
    Blood; 2002 Apr; 99(7):2625-6. PubMed ID: 11926185
    [No Abstract]   [Full Text] [Related]  

  • 89. Beetroot-Carrot Juice Intake either Alone or in Combination with Antileukemic Drug 'Chlorambucil' As A Potential Treatment for Chronic Lymphocytic Leukemia.
    Shakib MC; Gabrial SG; Gabrial GN
    Open Access Maced J Med Sci; 2015 Jun; 3(2):331-6. PubMed ID: 27275246
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Fast dissolving drug-drug eutectics with improved compressibility and synergistic effects.
    Thipparaboina R; Thumuri D; Chavan R; Naidu VGM; Shastri NR
    Eur J Pharm Sci; 2017 Jun; 104():82-89. PubMed ID: 28366649
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Function of granulocytes in B-chronic lymphatic leukaemia.
    Dekaris D; Handl S; Sabioncello A; Rabatić S
    Blut; 1990 Dec; 61(6):354-7. PubMed ID: 2291983
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Etodolac (1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid): a potent antiinflammatory drug. Conformation and absolute configuration of its active enantiomer.
    Humber LG; Demerson CA; Swaminathan P; Bird PH
    J Med Chem; 1986 May; 29(5):871-4. PubMed ID: 2939246
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Use of the MTT Chemosensitivity Assay in B-Cell Chronic Lymphocytic Leukemia.
    Foa R; Vischia F; Pini M; Lauria F; Guarini A
    Leuk Lymphoma; 1991; 5 Suppl 1():71-5. PubMed ID: 27463483
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A phase I/II trial of beta-(1,3)/(1,6) D-glucan in the treatment of patients with advanced malignancies receiving chemotherapy.
    Weitberg AB
    J Exp Clin Cancer Res; 2008 Sep; 27(1):40. PubMed ID: 18803849
    [TBL] [Abstract][Full Text] [Related]  

  • 95. R-etodolac is a more potent Wnt signaling inhibitor than enantiomer, S-etodolac.
    Roberts JS; Ma C; Robertson SYT; Kang S; Han CS; Deng SX; Zheng JJ
    Biochem Biophys Rep; 2022 Jul; 30():101231. PubMed ID: 35243012
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity.
    Quy AS; Li X; Male L; Stankovic T; Agathanggelou A; Fossey JS
    Tetrahedron; 2020 Nov; 76(48):131631. PubMed ID: 33299257
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Clinical efficacy and safety profile of etodolac: focus on the elderly.
    Bacon PA
    Eur J Rheumatol Inflamm; 1994; 14(1):1. PubMed ID: 7744122
    [No Abstract]   [Full Text] [Related]  

  • 98. Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases.
    Oprea TI; Sklar LA; Agola JO; Guo Y; Silberberg M; Roxby J; Vestling A; Romero E; Surviladze Z; Murray-Krezan C; Waller A; Ursu O; Hudson LG; Wandinger-Ness A
    PLoS One; 2015; 10(11):e0142182. PubMed ID: 26558612
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients.
    Guo Y; Kenney SR; Cook L; Adams SF; Rutledge T; Romero E; Oprea TI; Sklar LA; Bedrick E; Wiggins CL; Kang H; Lomo L; Muller CY; Wandinger-Ness A; Hudson LG
    Clin Cancer Res; 2015 Nov; 21(22):5064-72. PubMed ID: 26071482
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Targeting inflammatory pathways in chronic lymphocytic leukemia.
    Rozovski U; Keating MJ; Estrov Z
    Crit Rev Oncol Hematol; 2013 Dec; 88(3):655-66. PubMed ID: 23941728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.